Related Experiment Video
Updated: May 29, 2026
06:36
An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices
Published on: February 5, 2015
A mathematical model of cell death in multiple sclerosis
Taylor M Broome1, Randolph A Coleman
1Department of Chemistry Integrated Science Center, 540 Landrum Drive, The College of William and Mary, Williamsburg, VA 23187, USA.
Journal of Neuroscience Methods
|August 26, 2011
Summary
This study developed a mathematical model for multiple sclerosis (MS) using Biochemical Systems Theory (BST). The model simulates disease progression and evaluates experimental treatments, showing promise for preventing oligodendrocyte cell death.
Area of Science:
- Biochemistry
- Computational Biology
- Neuroscience
Background:
- Multiple Sclerosis (MS) is a neurodegenerative disease impacting the central nervous system.
- Oligodendrocyte dysfunction and cell death are key pathological features of MS.
- Reactive oxygen and nitrogen species (RONS) play a significant role in MS pathogenesis.
Purpose of the Study:
- To create a mathematical model of multiple sclerosis (MS) using Biochemical Systems Theory (BST).
- To investigate the role of RONS, the permeability transition pore (PTP), and apoptotic factors in oligodendrocyte cell death.
- To evaluate potential therapeutic interventions for MS.
Main Methods:
- Development of a mathematical model based on Biochemical Systems Theory (BST).
- Incorporation of known biological mechanisms and initial values from existing literature.
- Simulation of various treatment strategies, including an experimental PTP inhibition therapy.
Main Results:
- The model successfully simulates key aspects of MS pathology, including oligodendrocyte cell death.
- Simulations indicate that RONS and PTP opening contribute to cell death.
- An experimental treatment preventing PTP opening demonstrated positive therapeutic outcomes in the model.
Conclusions:
- Biochemical Systems Theory (BST) provides an effective framework for modeling MS.
- The developed model can be used to test drug therapies and identify disease triggers.
- Targeting the PTP represents a promising, albeit experimental, therapeutic strategy for MS.
Related Concept Videos
01:30Overview of Cell Death
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...